Citations

Citations to this article as recorded by  

• Molecular profiling and prognostic analysis in Chinese cholangiocarcinoma: an observational, retrospective single-center study
  Changkun Zhang, Xia You, Qin Zhang, Dong Wang
  Investigational New Drugs.2024; 42(1): 24.     CrossRef
• Radiographic features predictive of recurrence and survival after surgical resection of perihilar cholangiocarcinoma
  Julaluck Promsorn, Panjaporn Naknan, Aumkhae Sookprasert, Kosin Wirasorn, Jarin Chindaprasirt, Attapol Titapun, Piyapharom Intarawichian, Mukesh Harisinghani
  Heliyon.2024; 10(7): e28805.     CrossRef
• Practice guidelines for managing extrahepatic biliary tract cancers
  Hyung Sun Kim, Mee Joo Kang, Jingu Kang, Kyubo Kim, Bohyun Kim, Seong-Hun Kim, Soo Jin Kim, Yong-Il Kim, Joo Young Kim, Jin Sil Kim, Haeryoung Kim, Hyo Jung Kim, Ji Hae Nahm, Won Suk Park, Eunkyu Park, Joo Kyung Park, Jin Myung Park, Byeong Jun Song, Yong
  Annals of Hepato-Biliary-Pancreatic Surgery.2024; 28(2): 161.     CrossRef
• Influence of Perineural (Pn), Lymphangio (L) and Vascular (V) Invasion on Survival after Resection of Perihilar Cholangiocarcinoma
  Rabea Margies, Lisa-Katharina Gröger, Beate K. Straub, Fabian Bartsch, Hauke Lang
  Cancers.2024; 16(20): 3463.     CrossRef
• Liver transplantation for unresectable Klatskin tumor: experience of two centers, first distant results
  D. A. Granov, V. N. Zhuikov, I. I. Tileubergenov, A. V. Moiseenko, I. O. Rutkin, A. R. Sheraliev, A. A. Polikarpov, O. O. Rummo, A. E. Shcherba, I. P. Shturich, S. V. Korotkov, L. V. Kirkovsky, T. M. Chernishov
  Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery.2024; 29(3): 70.     CrossRef
• Significance of dysplasia in bile duct resection margin in patients with extrahepatic cholangiocarcinoma: A retrospective analysis
  Jung Wan Choe, Hyo Jung Kim, Jae Seon Kim
  World Journal of Clinical Cases.2022; 10(10): 3078.     CrossRef
• Klatskin Tumor: A Survival Analysis According to Tumor Characteristics and Inflammatory Ratios
  Vlad-Ionuţ Nechita, Emil Moiş, Luminiţa Furcea, Mihaela-Ancuţa Nechita, Florin Graur
  Medicina.2022; 58(12): 1788.     CrossRef
• Impact of Remnant Carcinoma in Situ at the Ductal Stump on Long‐Term Outcomes in Patients with Distal Cholangiocarcinoma
  Koya Yasukawa, Akira Shimizu, Hiroaki Motoyama, Koji Kubota, Tsuyoshi Notake, Kentaro Fukushima, Tomohiko Ikehara, Hikaru Hayashi, Akira Kobayashi, Yuji Soejima
  World Journal of Surgery.2021; 45(1): 291.     CrossRef
• Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients
  Feiling Feng, Xiaobing Wu, Xiaoliang Shi, Qingxiang Gao, Yue Wu, Yong Yu, Qingbao Cheng, Bin Li, Bin Yi, Chen Liu, Qing Hao, Lin Zhang, Chunfang Gao, Xiaoqing Jiang
  International Journal of Clinical Oncology.2021; 26(4): 717.     CrossRef
• Prognostic Impact of Perioperative CA19-9 Levels in Patients with Resected Perihilar Cholangiocarcinoma
  Jong Woo Lee, Jae Hoon Lee, Yejong Park, Jaewoo Kwon, Woohyung Lee, Ki Byung Song, Dae Wook Hwang, Song Cheol Kim
  Journal of Clinical Medicine.2021; 10(7): 1345.     CrossRef
• Prognostic Predictability of American Joint Committee on Cancer 8th Staging System for Perihilar Cholangiocarcinoma: Limited Improvement Compared with the 7th Staging System
  Jong Woo Lee, Jae Hoon Lee, Yejong Park, Woohyung Lee, Jaewoo Kwon, Ki Byung Song, Dae Wook Hwang, Song Cheol Kim
  Cancer Research and Treatment.2020; 52(3): 886.     CrossRef
• Comparative study of laparoscopic‐assisted and open total gastrectomy for Siewert Types II and III adenocarcinoma of the esophagogastric junction
  Jianchu Wang, Jin‐Cheng Wang, Bin Song, Xu‐Dong Dai, Xiao‐Yu Zhang
  Journal of Cellular Physiology.2019; 234(7): 11235.     CrossRef
• Surgical management of carcinoma in situ at ductal resection margins in patients with extrahepatic cholangiocarcinoma
  Toshifumi Wakai, Jun Sakata, Tomohiro Katada, Yuki Hirose, Daiki Soma, Pankaj Prasoon, Kohei Miura, Takashi Kobayashi
  Annals of Gastroenterological Surgery.2018; 2(5): 359.     CrossRef

Citations

Citations to this article as recorded by  

• An R0 resection margin does improve overall survival after PDAC resection– real-world evidence from 6.000 cases from the German Cancer Registry Group
  Lennart von Fritsch, Jannis Duhn, Thaer S.A. Abdalla, Kim C. Honselmann, Louisa Bolm, Rüdiger Braun, Markus Kist, Hryhoriy Lapshyn, Sylke Ruth Zeissig, Monika Klinkhammer-Schalke, Kees Kleihues van Tol, Stanislav Litkevych, Fabian Reinwald, Andrea Sackman
  European Journal of Surgical Oncology.2025; 51(6): 109693.     CrossRef
• Clinical outcomes in borderline and locally advanced pancreatic cancer with the addition of low-dose-rate brachytherapy to standard of care therapy
  Ross J. Taylor, Gregory J. Matthews, Robert H. Aseltine, Emma C. Fields
  Brachytherapy.2024; 23(3): 355.     CrossRef
• Laparoscopic radical antegrade modular pancreatosplenectomy (RAMPS) for adenocarcinoma of the body and tail of the pancreas — technical considerations with analysis of surgical outcomes
  Maciej Borys, Michał Wysocki, Krystyna Gałązka, Maciej Stanek, Andrzej Budzyński
  Langenbeck's Archives of Surgery.2024;[Epub]     CrossRef
• Neoadjuvant treatment for pancreatic cancer: Controversies and advances
  Douglas Dias e Silva, Vincent Chung
  Cancer Treatment and Research Communications.2024; 39: 100804.     CrossRef
• Stapled Arterial Divestment in Surgery for Locally Advanced Pancreatic Cancer
  Krishna Kotecha, Juanita Chui, Kai Brown, Anubhav Mittal, Jaswinder Samra
  Journal of Surgical Oncology.2024;[Epub]     CrossRef
• Evaluation of local recurrence after pancreaticoduodenectomy for borderline resectable pancreatic head cancer with neoadjuvant chemotherapy: Can the resection level change after chemotherapy?
  Kosuke Kobayashi, Yoshihiro Ono, Shoki Sato, Tomotaka Kato, Atsushi Oba, Takafumi Sato, Hiromichi Ito, Yosuke Inoue, Manabu Takamatsu, Akio Saiura, Yu Takahashi
  Surgery.2023; 173(5): 1220.     CrossRef
• Rhabdoid carcinoma of the pancreas: A rare cause of unidentified carcinomas of the pancreas
  Ayoub Madani, Anass Derkaoui, Tarik Deflaoui, Hanane El Aggari, Nadir Miry, Benani Amal, Rachid Jabi, Mohamed Bouziane
  Surgery Open Digestive Advance.2023; 9: 100076.     CrossRef
• Prognostic significance of margin clearance in pancreaticoduodenectomy specimens with pancreatic ductal adenocarcinoma in a Danish population-based nationwide study
  Trine Aaquist, Claus W. Fristrup, Jane P. Hasselby, Stephen Hamilton-Dutoit, Mikkel Eld, Per Pfeiffer, Michael B. Mortensen, Sönke Detlefsen
  HPB.2023; 25(7): 826.     CrossRef
• Practice Patterns and Survival in Patients with Resected Pancreatic Ductal Adenocarcinomas (PDAC) — Results from the Multicentre Indian Pancreatic & Periampullary Adenocarcinoma Project (MIPPAP) Study
  Vikram Chaudhari, Anant Ramaswamy, Sujay Srinivas, Ajit Agarwal, Ramakrishnan Ayloor Seshadri, Vineet Talwar, Prabhat Bhargava, Shaifali Goel, Smita Kayal, Pradeep Rebala, Bharat Prajapati, Devendra Parikh, Jagdish Kothari, Ramesh M. Ch, Jacob Mathew Kada
  Journal of Gastrointestinal Cancer.2023; 54(4): 1338.     CrossRef
• Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9
  Dengfeng Li, Qing Peng, Leyao Wang, Wei Cai, Meng Liang, Siyun Liu, Xiaohong Ma, Xinming Zhao
  European Radiology.2023; 34(1): 509.     CrossRef
• Predicting resection margin status of pancreatic neuroendocrine tumors on CT: performance of NCCN resectability criteria
  Dong Hwan Kim, Bohyun Kim, Dong Jin Chung, Kyung Ah Kim, Su Lim Lee, Moon Hyung Choi, Hokun Kim, Sung Eun Rha
  The British Journal of Radiology.2023;[Epub]     CrossRef
• Biliary Adverse Events during Neoadjuvant Therapy for Pancreatic Cancer
  Sam Z. Thalji, Deemantha Fernando, Kulwinder S. Dua, Srivats Madhavan, Phillip Chisholm, Zachary L. Smith, Mohammed Aldakkak, Kathleen K. Christians, Callisia N. Clarke, Ben George, Mandana Kamgar, Beth A. Erickson, William A. Hall, Douglas B. Evans, Susa
  Annals of Surgery.2023;[Epub]     CrossRef
• Lymph Node Stations of Pancreas Which Are Identified in Real Color Sectioned Images of a Cadaver With Pancreatic Cancer
  Chung Yoh Kim, Yongwook Jung, Jin Seo Park
  Journal of Korean Medical Science.2023;[Epub]     CrossRef
• CivaSheet intraoperative radiation therapy for pancreatic cancer
  Ross J. Taylor, Dorin Todor, Brian J. Kaplan, Weston Stover, Emma C. Fields
  Brachytherapy.2022; 21(2): 255.     CrossRef
• Four-Tier Pathologic Tumor Regression Grading System Predicts the Clinical Outcome in Patients Who Undergo Surgical Resection for Locally Advanced Pancreatic Cancer after Neoadjuvant Chemotherapy
  Soomin Ahn, Jong-chan Lee, Jaihwan Kim, Young Hoon Kim, Yoo-Seok Yoon, Ho-Seong Han, Haeryoung Kim, Jin-Hyeok Hwang
  Gut and Liver.2022; 16(1): 129.     CrossRef
• Preoperative Serum Carbohydrate Antigen 19-9 Levels Cannot Predict the Surgical Resectability of Pancreatic Cancer: A Meta-Analysis
  Márton Benke, Nelli Farkas, Péter Hegyi, Benedek Tinusz, Patrícia Sarlós, Bálint Erőss, Kata Szemes, Nóra Vörhendi, Zsolt Szakács, Ákos Szücs
  Pathology and Oncology Research.2022;[Epub]     CrossRef
• Neoadjuvant therapy in pancreatic ductal adenocarcinoma: A competing risk analysis
  Carlo Alberto Pacilio, Elisa Grassi, Andrea Gardini, Francesca Fappiano, Alessandro Passardi, Giovanni Luca Frassineti, Stefano Tamberi, Giorgio Ercolani
  Surgical Practice.2022; 26(3): 155.     CrossRef
• Prediction of tumour grade and survival outcome using pre-treatment PET- and MRI-derived imaging features in patients with resectable pancreatic ductal adenocarcinoma
  Vincent Dunet, Nermin Halkic, Christine Sempoux, Nicolas Demartines, Michael Montemurro, John O. Prior, Sabine Schmidt
  European Radiology.2021; 31(2): 992.     CrossRef
• First report on the feasibility of a permanently implantable uni-directional planar low dose rate brachytherapy sheet for patients with resectable or borderline resectable pancreatic cancer
  Joshua B. Dault, Dorin Todor, Brian J. Kaplan, Jennifer L. Myers, Emma C. Fields
  Brachytherapy.2021; 20(1): 207.     CrossRef
• Periarterial divestment in pancreatic cancer surgery
  Markus K. Diener, André L. Mihaljevic, Oliver Strobel, Martin Loos, Thomas Schmidt, Martin Schneider, Christoph Berchtold, Arianeb Mehrabi, Beat P. Müller-Stich, Kuirong Jiang, John P. Neoptolemos, Thilo Hackert, Yi Miao, Markus W. Büchler
  Surgery.2021; 169(5): 1019.     CrossRef
• Advances and challenges of neoadjuvant therapy in pancreatic cancer
  Yang Yu, Peng Zheng, Yajing Chen, Bofang Wang, Maswikiti Ewetse Paul, Pengxian Tao, Dengfeng Wang, Haiyuan Li, Baohong Gu, Lei Gao, Dan Wang, Hao Chen
  Asia-Pacific Journal of Clinical Oncology.2021; 17(6): 425.     CrossRef
• R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma
  Stefano Crippa, Fabio Giannone, Marco Schiavo Lena, Giulio Belfiori, Stefano Partelli, Domenico Tamburrino, Roberto Delpini, Michele Pagnanelli, Nicolo Pecorelli, Gianpaolo Balzano, Claudio Doglioni, Massimo Falconi
  Annals of Surgical Oncology.2021; 28(8): 4602.     CrossRef
• Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy
  Ryan K. Schmocker, Daniel Delitto, Michael J. Wright, Ding Ding, John L. Cameron, Kelly J. Lafaro, William R. Burns, Christopher L. Wolfgang, Richard A. Burkhart, Jin He
  Journal of the American College of Surgeons.2021; 232(4): 405.     CrossRef
• A Novel DNA Replication-Related Signature Predicting Recurrence After R0 Resection of Pancreatic Ductal Adenocarcinoma: Prognostic Value and Clinical Implications
  Zengyu Feng, Kexian Li, Jianyao Lou, Mindi Ma, Yulian Wu, Chenghong Peng
  Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
• Impact of resection margin status on survival in advanced N stage pancreatic cancer – a multi-institutional analysis
  Christian Teske, Richard Stimpel, Marius Distler, Susanne Merkel, Robert Grützmann, Louisa Bolm, Ulrich Wellner, Tobias Keck, Daniela E. Aust, Jürgen Weitz, Thilo Welsch
  Langenbeck's Archives of Surgery.2021; 406(5): 1481.     CrossRef
• Radical antegrade modular pancreatosplenectomy (RAMPS) versus conventional distal pancreatectomy for left-sided pancreatic cancer: findings of a multicenter, retrospective, propensity score matching study
  Hyung Sun Kim, Tae Ho Hong, Young-Kyoung You, Joon Seong Park, Dong Sup Yoon
  Surgery Today.2021; 51(11): 1775.     CrossRef
• What do surgeons need to know about the mesopancreas
  Eduardo de Souza M. Fernandes, Oliver Strobel, Camila Girão, Jose Maria A. Moraes-Junior, Orlando Jorge M. Torres
  Langenbeck's Archives of Surgery.2021; 406(8): 2621.     CrossRef
• Room for improvement in the treatment of pancreatic cancer: Novel opportunities from gene targeted therapy
  Michail Galanopoulos, Aris Doukatas, Filippos Gkeros, Nikos Viazis, Christos Liatsos
  World Journal of Gastroenterology.2021; 27(24): 3568.     CrossRef
• Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021)
  Yinmo Yang, Xueli Bai, Dapeng Bian, Shouwang Cai, Rufu Chen, Feng Cao, Menghua Dai, Chihua Fang, Deliang Fu, Chunlin Ge, Xiaochao Guo, Chunyi Hao, Jihui Hao, Heguang Huang, Zhixiang Jian, Gang Jin, Fei Li, Haimin Li, Shengping Li, Weiqin Li, Yixiong Li, H
  Journal of Pancreatology.2021; 4(2): 49.     CrossRef
• Paraaortic dissection in “total mesopancreas excision” and “mesopancreas-first resection” pancreaticoduodenectomies for pancreatic cancer: Useless, optional, or necessary?A systematic review
  Nadia Peparini
  Surgical Oncology.2021; 38: 101639.     CrossRef
• Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduodenectomy
  Yuki Sunagawa, Masamichi Hayashi, Suguru Yamada, Hiroshi Tanabe, Keisuke Kurimoto, Nobutake Tanaka, Fuminori Sonohara, Yoshikuni Inokawa, Hideki Takami, Mitsuro Kanda, Chie Tanaka, Goro Nakayama, Masahiko Koike, Yasuhiro Kodera
  Clinical Epigenetics.2021;[Epub]     CrossRef
• Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP)
  Jae Seung Kang, Lydia Mok, Jin Seok Heo, In Woong Han, Sang Hyun Shin, Yoo-Seok Yoon, Ho-Seong Han, Dae Wook Hwang, Jae Hoon Lee, Woo Jung Lee, Sang Jae Park, Joon Seong Park, Yonghoon Kim, Huisong Lee, Young-Dong Yu, Jae Do Yang, Seung Eun Lee, Il Young
  Gut and Liver.2021; 15(6): 912.     CrossRef
• Arterial Divestment and Resection in Post-neoadjuvant Pancreatic Adenocarcinoma
  Yugal Limbu, Sujan Regmee, Roshan Ghimire, Dhiresh Kumar Maharjan, Prabin Bikram Thapa
  Cureus.2021;[Epub]     CrossRef
• Recurrence patterns of pancreatic cancer after pancreatoduodenectomy: systematic review and a single-centre retrospective study
  Marit Kalisvaart, Damian Broadhurst, Francesca Marcon, Rupaly Pande, Andrea Schlegel, Robert Sutcliffe, Ravi Marudanayagam, Darius Mirza, Nikolaos Chatzizacharias, Manuel Abradelo, Paolo Muiesan, John Isaac, Yuk T. Ma, Christopher McConville, Keith Robert
  HPB.2020; 22(9): 1240.     CrossRef
• Positive neck margin at frozen section analysis is a significant predictor of tumour recurrence and poor survival after pancreatodudenectomy for pancreatic cancer
  Stefano Crippa, Giovanni Guarneri, Giulio Belfiori, Stefano Partelli, Michele Pagnanelli, Giulia Gasparini, Gianpaolo Balzano, Marco Schiavo Lena, Corrado Rubini, Claudio Doglioni, Giuseppe Zamboni, Massimo Falconi
  European Journal of Surgical Oncology.2020; 46(8): 1524.     CrossRef
• Resection or repair of large peripancreatic arteries during robotic pancreatectomy
  Emanuele F. Kauffmann, Niccolò Napoli, Concetta Cacace, Francesca Menonna, Fabio Vistoli, Gabriella Amorese, Ugo Boggi
  Updates in Surgery.2020; 72(1): 145.     CrossRef
• In the Era of the Leeds Protocol: A Systematic Review and A Meta-Analysis on the Effect of Resection Margins on Survival Among Pancreatic Ductal Adenocarcinoma Patients
  B. Kurlinkus, R. Ahola, E. Zwart, A. Halimi, B. S. Yilmaz, G. O. Ceyhan, J. Laukkarinen
  Scandinavian Journal of Surgery.2020; 109(1): 11.     CrossRef
• Systematic Analysis of Accuracy in Predicting Complete Oncological Resection in Pancreatic Cancer Patients—Proposal of a New Simplified Borderline Resectability Definition
  Louisa Bolm, Katharina Mueller, Katharina May, Stefan Sondermann, Ekaterina Petrova, Hryhoriy Lapshyn, Kim Christin Honselmann, Dirk Bausch, Sergii Zemskov, Peter Bronsert, Tobias Keck, Steffen Deichmann, Ulrich F. Wellner
  Cancers.2020; 12(4): 882.     CrossRef
• Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study
  Hongcheng Wang, Jiazhe Liu, Guanggai Xia, Shizhou Lei, Xiuyan Huang, Xinyu Huang
  Scientific Reports.2020;[Epub]     CrossRef
• Circumferential resection margin (CRM) in pancreatic cancer
  Lena Häberle, Irene Esposito
  Surgery in Practice and Science.2020; 1: 100006.     CrossRef
• Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma
  Tsengelmaa Jamiyan, Takayuki Shiraki, Yoshihiro Kurata, Masanori Ichinose, Keiichi Kubota, Yasuo Imai
  World Journal of Surgical Oncology.2020;[Epub]     CrossRef
• Prognostic Implications of 18-FDG Positron Emission Tomography/Computed Tomography in Resectable Pancreatic Cancer
  Cosimo Sperti, Alberto Friziero, Simone Serafini, Sergio Bissoli, Alberto Ponzoni, Andrea Grego, Emanuele Grego, Lucia Moletta
  Journal of Clinical Medicine.2020; 9(7): 2169.     CrossRef
• Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
  Aaron J. Grossberg, Linda C. Chu, Christopher R. Deig, Eliot K. Fishman, William L. Hwang, Anirban Maitra, Daniel L. Marks, Arnav Mehta, Nima Nabavizadeh, Diane M. Simeone, Colin D. Weekes, Charles R. Thomas
  CA: A Cancer Journal for Clinicians.2020; 70(5): 375.     CrossRef
• Survival benefit of adjuvant chemoradiotherapy for positive or close resection margin after curative resection of pancreatic adenocarcinoma
  Byoung Hyuck Kim, Kyubo Kim, Jin-Young Jang, Wooil Kwon, Hongbeom Kim, Kyung-Hun Lee, Do-Youn Oh, Haeryoung Kim, Kyung Bun Lee, Eui Kyu Chie
  European Journal of Surgical Oncology.2020; 46(11): 2122.     CrossRef
• Pre‐operative diabetes mellitus does not worsen survival and post‐operative outcomes in Chinese patients undergoing resection for pancreatic adenocarcinoma
  Adrian H. K. Yu, Albert C. Y. Chan
  Surgical Practice.2020; 24(4): 132.     CrossRef
• Multiagent neoadjuvant chemotherapy and tumor response are associated with improved survival in pancreatic cancer
  Nathan M. Bolton, Adam H. Maerz, Russell E. Brown, Mona Bansal, John S. Bolton, William C. Conway
  HPB.2019; 21(4): 413.     CrossRef
• The learning curve for a surgeon in robot-assisted laparoscopic pancreaticoduodenectomy: a retrospective study in a high-volume pancreatic center
  Tao Zhang, Zhi-Ming Zhao, Yuan-Xing Gao, Wan Yee Lau, Rong Liu
  Surgical Endoscopy.2019; 33(9): 2927.     CrossRef
• Selecting chemotherapy for pancreatic cancer: Far away or so close?
  Si Shi, Xianjun Yu
  Seminars in Oncology.2019; 46(1): 39.     CrossRef
• Adjuvant chemotherapy followed by concurrent chemoradiation is associated with improved survival for resected stage I‐II pancreatic cancer
  Sung Jun Ma, Gregory M. Hermann, Kavitha M. Prezzano, Lucas M. Serra, Austin J. Iovoli, Anurag K. Singh
  Cancer Medicine.2019; 8(3): 939.     CrossRef
• Duktales Adenokarzinom des Pankreas
  E. Gallmeier, T. M. Gress
  Der Gastroenterologe.2019; 14(2): 131.     CrossRef
• Management of pancreatic head adenocarcinoma: From where to where?
  Kemal Dolay, Fatma Umit Malya, Sami Akbulut
  World Journal of Gastrointestinal Surgery.2019; 11(3): 143.     CrossRef
• Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma
  Vincent P. Groot, Georgios Gemenetzis, Alex B. Blair, Roberto J. Rivero-Soto, Jun Yu, Ammar A. Javed, Richard A. Burkhart, Inne H. M. Borel Rinkes, I. Quintus Molenaar, John L. Cameron, Matthew J. Weiss, Christopher L. Wolfgang, Jin He
  Annals of Surgery.2019; 269(6): 1154.     CrossRef
• A Prospective Clinical Trial to Determine the Effect of Intraoperative Ultrasound on Surgical Strategy and Resection Outcome in Patients with Pancreatic Cancer
  Babs G. Sibinga Mulder, Shirin Feshtali, Arantza Fariña Sarasqueta, Alexander L. Vahrmeijer, Rutger-Jan Swijnenburg, Bert A. Bonsing, J. Sven D. Mieog
  Ultrasound in Medicine & Biology.2019; 45(8): 2019.     CrossRef
• Microvascular invasion is a major prognostic factor after pancreatico‐duodenectomy for adenocarcinoma
  Fabrizio Panaro, Tarek Kellil, Julie Vendrell, Valentina Sega, Regis Souche, Tullio Piardi, Piera Leon, Christophe Cassinotto, Eric Assenat, Edoardo Rosso, Francis Navarro
  Journal of Surgical Oncology.2019; 120(3): 483.     CrossRef
• Role of surgical resection in the era of FOLFIRINOX for advanced pancreatic cancer
  Yoonhyeong Byun, Youngmin Han, Jae Seung Kang, Yoo Jin Choi, Hongbeom Kim, Wooil Kwon, Sun‐Whe Kim, Do‐Youn Oh, Sang Hyub Lee, Ji Kon Ryu, Yong‐Tae Kim, Jin‐Young Jang
  Journal of Hepato-Biliary-Pancreatic Sciences.2019; 26(9): 416.     CrossRef
• Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer
  Lucia Roa-Peña, Cindy V. Leiton, Sruthi Babu, Chun-Hao Pan, Elizabeth A. Vanner, Ali Akalin, Jela Bandovic, Richard A. Moffitt, Kenneth R. Shroyer, Luisa F. Escobar-Hoyos
  Scientific Reports.2019;[Epub]     CrossRef
• Comment on “The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma”
  Niccolo Petrucciani, Laura Antolino, Giovanni Moschetta, Giovanni Ramacciato
  Annals of Surgery.2019; 270(6): e129.     CrossRef
• Determining Optimal Routes to Surgery for Borderline Resectable Venous Pancreatic Cancer—Where Is the Least Harm and Most Benefit?
  Rupaly Pandé, Keith J. Roberts
  Frontiers in Oncology.2019;[Epub]     CrossRef
• Duktales Adenokarzinom des Pankreas
  E. Gallmeier, T. M. Gress
  Der Internist.2018; 59(8): 805.     CrossRef
• Adjuvant Chemotherapy Versus Chemoradiation for Patients with Resected Pancreatic Adenocarcinoma: A Single-Center Retrospective Study
  Do Young Kim, Young Jin Choi, Young Mi Seol, Hyojeong Kim
  The Korean Journal of Pancreas and Biliary Tract.2018; 23(3): 108.     CrossRef
• Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
  Andrew McGuigan, Paul Kelly, Richard C Turkington, Claire Jones, Helen G Coleman, R Stephen McCain
  World Journal of Gastroenterology.2018; 24(43): 4846.     CrossRef
• Combined hepatic arterial resection in pancreatic resections for locally advanced pancreatic cancer
  Masaru Miyazaki, Hideyuki Yoshitomi, Shigetsugu Takano, Hiroaki Shimizu, Atsushi Kato, Hiroyuki Yoshidome, Katunori Furukawa, Tsukasa Takayashiki, Satoshi Kuboki, Daisuke Suzuki, Nozomu Sakai, Masayuki Ohtuka
  Langenbeck's Archives of Surgery.2017; 402(3): 447.     CrossRef
• The TRIANGLE operation – radical surgery after neoadjuvant treatment for advanced pancreatic cancer: a single arm observational study
  Thilo Hackert, Oliver Strobel, Christoph W. Michalski, André L. Mihaljevic, Arianeb Mehrabi, Beat Müller-Stich, Christoph Berchtold, Alexis Ulrich, Markus W. Büchler
  HPB.2017; 19(11): 1001.     CrossRef

Citations

Citations to this article as recorded by  

• Efficacy of postoperative radiotherapy in esophageal squamous cell carcinoma patients with positive circumferential resection margin
  Reiko Otake, Akihiko Okamura, Kotaro Yamashita, Yu Imamura, Jun Kanamori, Ryotaro Kozuki, Keita Takahashi, Tasuku Toihata, Noriko Yamamoto, Takao Asari, Shinji Mine, Masayuki Watanabe
  Esophagus.2021; 18(2): 288.     CrossRef
• The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma
  Andrew T. Wong, Meng Shao, Justin Rineer, Anna Lee, David Schwartz, David Schreiber
  Annals of Surgery.2017; 265(6): 1146.     CrossRef
• Alpha linolenic acid and oleic acid additively down-regulate malignant potential and positively cross-regulate AMPK/S6 axis in OE19 and OE33 esophageal cancer cells
  Hyun-Seuk Moon, Saime Batirel, Christos S. Mantzoros
  Metabolism.2014; 63(11): 1447.     CrossRef